Skip to main content
SpringerLink
Log in

Absence of p53 Alterations in Nasopharyngeal Carcinoma Spanish Patients with Epstein–Barr Virus Infection

  • Published:
Virus Genes Aims and scope Submit manuscript

Abstract

The objective of this study was to analyse the relationships between the Epstein–Barr virus (EBV) infection and the molecular abnormalities of the p53 oncoprotein in the nasopharyngeal carcinoma (NPC). Fifty-five NPC paraffin samples from a group of Spanish patients with EBV demonstrated presence by nested-PCR and non-isotopic in situ hybridisation, were analysed for p53 expression using immunohistochemistry. The positive samples by immunohistochemistry were studied for p53 gene alterations in the exon 5 by single strand conformation polymorphism (SSCP). Among the 55 specimens, 14 (25.5%) showed expression of p53 protein. All these positive samples corresponded to the late stage of the tumour. Of the 14 samples, p53 gene alterations were found only in three cases using SSCP. These results indicate that the p53 mutations are an infrequent event in NPC in Spanish patients needing exogenous factors as the EBV infection for the development of this malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liebowitz D., Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 21, 376-381, 1994.

    Google Scholar 

  2. Pathmanathan R., Prasad U., Sadler R., Flynn K., and Raab-Traub N., Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333, 693-698, 1995.

    Google Scholar 

  3. Shanmugaratnam K. and Sobin I.H., Histological Typing of Upper Respiratory Tract Tumours. International Histological Classification of Tumours. N° 19., WHO, Geneva, 286 pp, 1978.

    Google Scholar 

  4. Micheau C., What's new in histological classification and recognition of nasopharyngeal carcinoma?. Pathol Res Pract 181, 249-253, 1986.

    Google Scholar 

  5. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C., p53 mutations in human cancers. Science 253, 49-53, 1991.

    Google Scholar 

  6. Levine A.J., Momand J., and Finlay C.A., The p53 tumor suppressor gene. Nature 351, 453-456, 1991.

    Google Scholar 

  7. Chang F., Syrjanen S., Tervahauta A., and Syrjanen K., Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer 68, 653-661, 1993.

    Google Scholar 

  8. Harris C.C., Chemical and physical carcinogenesis: Advances and perspectives for the 1990's. Cancer Res 51, 5023-5044, 1991.

    Google Scholar 

  9. Werness B.A., Levine A.J., and Howley P.M., Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79, 1990.

    Google Scholar 

  10. Iggo R., Gatter K., Bartek J., Lane D., and Harris A.L., Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335, 675-679, 1990.

    Google Scholar 

  11. Maestro R., Dolcetti R., Gasparotto D., Doglioni C., Pelucchi S., Barzan L., Grandi E., and Boiocchi M., High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 7, 1159-1166, 1992.

    Google Scholar 

  12. Sakai E. and Tsuchida N., Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 7, 927-933, 1992.

    Google Scholar 

  13. Niedobitek G., Agathanggelou A., Barber P., Smallman L.A., Jones E.L., and Young L.S., p53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 170, 457-461, 1993.

    Google Scholar 

  14. Niedobitek G. and Young L.S., Epstein-Barr virus persistence and virus associated tumor. Lancet 343, 333-335, 1994.

    Google Scholar 

  15. Niemhom S., Kitazawa S., Murao S., Kunachak S., and Maeda S., Co-expression of p53 and bc1-2 may correlate to the presence of Epstein-Barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Cancer Lett 160, 199-208, 2000.

    Google Scholar 

  16. Spruck C.H. 3rd, Tsai Y.C., Huang D.P., Yang A.S., Rideout W.M. 3rd, Gonzalez-Zulueta M., Choi P., Lo K.W., Yu M.C., and Jones P.A., Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res 52, 4787-4790, 1992.

    Google Scholar 

  17. Sun Y., Hegamyer G., Cheng Y.J., Hildesheim A., Chen J.Y., Chen I.H., Cao Y., Yao K.T., and Colburn N.H., An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA 89, 6516-6520, 1992.

    Google Scholar 

  18. Nasrin N., Taiba K., Hannan N., Hannan M., and al-Sedairy S., A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients. Cancer Lett 82, 189-198, 1994.

    Google Scholar 

  19. Kouvidou C., Stefanaki K., Dai Y., Tzardi M., Koutsoubi K., Darivianaki K., Karidi E., Rontogianni D., Zois E., Kakolyris S., Georgoulias V., Delides G., and Kanavaros P., P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression. Anticancer Res 17, 2615-2619, 1997.

    Google Scholar 

  20. Lung M.L., Hu Y., Cheng Y., Li M.F., Tang C.M., O S.K., and Iggo R.D., p53 inactivating mutations in Chinese nasopharyngeal carcinomas. Cancer Lett 133, 89-94, 1998.

    Google Scholar 

  21. Gabusi E., Lattes C., Fiorentino M., D'Errico A., and Grigioni W.F, Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas. J Exp Clin Cancer Res 20, 371-376, 2001.

    Google Scholar 

  22. Shi W., Pataki I., MacMillan C., Pintilie M., Payne D., O'Sullivan B., Cummings B.J., Warde P., and Liu F.F., Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer 94, 1997-2006, 2002.

    Google Scholar 

  23. Chakrani F., Armand J.P., Lenoir G., Ju L.Y., Liang J.P., May E., and May P., Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia. Int J Cancer 61, 316-320, 1995.

    Google Scholar 

  24. Vera-Sempere F., Burgos J., Botella M.S., and Morera C., Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma (NPC). Clin Chim Acta 271, 119-132, 1998.

    Google Scholar 

  25. Vera-Sempere F.J., Burgos J.S., Botella M.S., Cordoba J., and Gobernado M., Immunohistochemical expression of the Epstein-Barr virus-encoded latent membrane protein (LMP1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients. Eur J Cancer B Oral Oncol 32, 163-168, 1996.

    Google Scholar 

  26. Vera-Sempere F.J., Burgos J.S., Botella M.S., and Morera C., Immunohistochemical expression of Bc1-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival. Histol Histopathol 12, 9-18, 1997.

    Google Scholar 

  27. Vojtesec B., Bartek J., and Midgley C.A., An immunohistochemical analysis of human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Meth 151, 237-244, 1992.

    Google Scholar 

  28. Wood G.S. and Warnke R., Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 29, 1196-1204, 1981.

    Google Scholar 

  29. Castresana J.S., Rubio M.P., Vazquez J.J., Idoate M., Sober A.J., Seizinger B.R., and Barnhill R.L., Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer 55, 562-565, 1993.

    Google Scholar 

  30. Orita M., Suzuki Y., Sekiya T., and Hayashi K., Rapid and sensitive detection of point mutations and DNA ploymorphism using the polymerase chain reaction. Genomics 5, 874-879, 1989.

    Google Scholar 

  31. Maghtah I.J. and Bhatia K., Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 3, 285-295, 1992.

    Google Scholar 

  32. Deacon E.M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A.B., and Young L.S., Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177, 339-349, 1993.

    Google Scholar 

  33. Ballerini P., Gaidano G., Gonz J.Z., Tassi V., Saglio G., Knowles D.M., and Dalla-Favera R., Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 81, 166-176, 1993.

    Google Scholar 

  34. Chen W. and Cooper N.R., Epstein-Barr virus nuclear 2 and latent membrane protein independently transactivate p53 through induction of NF-KappaB activity. J Virol 70, 4849-4853, 1996.

    Google Scholar 

  35. Fries K.L., Miller W.E., and Raab-Traub N., Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol 70, 8653-8659, 1996.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro de Biología Molecular “Severo Ochoa” – C.S.I.C., Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain

    Javier S. Burgos

Authors
  1. Javier S. Burgos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javier S. Burgos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burgos, J.S. Absence of p53 Alterations in Nasopharyngeal Carcinoma Spanish Patients with Epstein–Barr Virus Infection. Virus Genes 27, 263–268 (2003). https://doi.org/10.1023/A:1026347900050

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026347900050

Search

Navigation